Balance Sheet
Daily Values
Growth Metrics
Income Statement
Revenue
Others
Ratios

China SXT Pharmaceuticals (SXTC) Shares Outstanding (Weighted Average) (2018 - 2022)

China SXT Pharmaceuticals (SXTC) has 6 years of Shares Outstanding (Weighted Average) data on record, last reported at $1.4 million in Q1 2025.

  • For Q1 2025, Shares Outstanding (Weighted Average) changed N/A year-over-year to $1.4 million; the TTM value through Mar 2025 reached $1.4 million, changed N/A, while the annual FY2025 figure was $1.4 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $1.4 million in Q1 2025 per SXTC's latest filing, up from $41591.0 in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $1.4 million in Q1 2025 and bottomed at $41591.0 in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 3 years is $728147.0, with a median of $719549.0 recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 132.78% in 2021, then tumbled 94.22% in 2022.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $719549.0 in 2021, then crashed by 94.22% to $41591.0 in 2022, then skyrocketed by 3322.14% to $1.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $1.4 million in Q1 2025, $41591.0 in Q1 2022, and $719549.0 in Q1 2021.